Phase II study of regorafenib with dose adjustment and pharmacokinetic analysis in advanced colorectal cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2018
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 16 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Aug 2016 Status changed from not yet recruiting to recruiting.
- 02 Aug 2016 New trial record